(Total Views: 438)
Posted On: 10/23/2019 10:12:07 AM
Post# of 72441
J&J's Crohn's Disease drug fails in clinical trial -- BUT, the clinical trial is suspect because the response to placebo was an astonishing 85%. If a placebo could get these kinds of results, we wouldn't really NEED real drugs for something as devastating as Crohn's.
Where have we seen unusually high placebo response affecting apparent results before? Hmm, let me think.....
https://endpts.com/provention-bios-jj-license...age-study/
So it isn't just small companies that get unusually high placebo responses messing up their clinical trials. But it USUALLY is small companies that magically are affected by this problem.
It's time to stop giving patients placebos and start using population data as the control group, so that this kind of nonsense (or shenanigans) doesn't affect the futures of potentially helpful drugs.
Where have we seen unusually high placebo response affecting apparent results before? Hmm, let me think.....
https://endpts.com/provention-bios-jj-license...age-study/
So it isn't just small companies that get unusually high placebo responses messing up their clinical trials. But it USUALLY is small companies that magically are affected by this problem.
It's time to stop giving patients placebos and start using population data as the control group, so that this kind of nonsense (or shenanigans) doesn't affect the futures of potentially helpful drugs.
(4)
(1)Scroll down for more posts ▼
